Abstract The WHO (World Health Organization) conducted an elimination of cervical cancer
program using triple pillar intervention strategy to target 90%-70%-90% of women before the …

METHODS We conducted a PubMed search on January 3, 2024, of English language
articles published since 2000, using the following keywords: human papillomavirus, cervical …

Cervical cancer (CC) screening in women comprises human papillomavirus (HPV) testing
followed by cytology triage of positive cases. Drawbacks, including cytology's low …

Background Persistent infection with high-risk human papillomavirus (HR-HPV) plays a key
role in the onset of cervical cancer. This study was designed to examine the epidemiological …

To achieve cervical cancer elimination globally, cervical screening must be delivered in an
inclusive, culturally safe and context-appropriate manner. There are multiple tools and …

While the incidence of cervical cancer has dropped in high‐income countries due to
organized cytology‐based screening programs, it remains the leading cause of cancer …

Objectives The World Health Organization supports both the screen-and-treat (ST) approach
and the screen, triage and treat (STT) approach to cervical cancer screening using high-risk …

Background: Cervical cancer occurs 80% in developing country including Indonesia and
take place in the first rank of incidence rate and third rank in mortality rate in Asian Pacific …

Purpose Cervical cancer remains a significant health concern, particularly in developing
countries, where it is a leading cause of cancer-related deaths among women. Innovative …

Human papillomavirus (HPV) vaccines received regulatory approval and were
recommended for use in young girls nearly 2 decades ago. Uptake is mostly high in …